Page last updated: 2024-10-24

carisoprodol and Hemophilia A

carisoprodol has been researched along with Hemophilia A in 1 studies

Carisoprodol: A centrally acting skeletal muscle relaxant whose mechanism of action is not completely understood but may be related to its sedative actions. It is used as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1202)
carisoprodol : A carbamate ester that is the mono-N-isopropyl derivative of meprobamate (which is a significant metabolite). Carisoprodol interrupts neuronal communication within the reticular formation and spinal cord, resulting in sedation and alteration in pain perception. It is used as a muscle relaxant in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm.

Hemophilia A: The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rashidi, A1
Bhasin, M1

Other Studies

1 other study available for carisoprodol and Hemophilia A

ArticleYear
Pulmonary emboli in a patient with haemophilia: a case report.
    Haemophilia : the official journal of the World Federation of Hemophilia, 2012, Volume: 18, Issue:1

    Topics: Adult; Carisoprodol; Diagnosis, Differential; Foreign Bodies; Hemophilia A; Humans; Injections, Intr

2012